| Optimum management of asthma in pregnancy. | |
| | |
MedLine Citation:
|
PMID: 3091354 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In pregnancy complicated by asthma, the greatest risk to the fetus is severe and uncontrolled bronchospasm resulting in hypoxia. For this reason, the priority in management of the pregnant asthmatic should be effective control of asthma symptoms with an appropriate amount of asthma medication to accomplish this goal. In general, the management of the pregnant asthmatic does not differ greatly from that of the non-pregnant asthmatic. Virtually none of the commonly used asthma medications are totally contraindicated in pregnancy if their use is justified by the severity of the asthma in pregnancy. These include optimising non-pharmacological means of controlling symptoms, using the smallest doses of antiasthma drugs necessary to control symptoms, basing the decision to use a drug on its benefit-to-risk ratio, avoiding recently introduced drugs (for which safety in pregnancy has not been adequately established), and using the inhaled route in preference to the oral route of administration. Ideally any changes in management should be made before the anticipated pregnancy. Well-controlled asthma appears to pose little risk to either the pregnant mother or the fetus and a favourable outcome of the pregnancy should be anticipated. The patient's justifiable anxiety can often be alleviated by ensuring that she fully understands the objectives of her management and participates in it. |
| | |
Authors:
|
H Mawhinney; S L Spector |
Related Documents
:
|
18294334 - Prescription drug use among fathers and mothers before and during pregnancy. a populati... 12609194 - Current management of epilepsy and pregnancy: fetal outcome, congenital malformations, ... 18552414 - Pregnancy outcomes in asthmatic women. 7904984 - Headaches and women: treatment of the pregnant and lactating migraineur. 17281804 - Instrumentation for fetal cardiac performance analysis during the antepartum period. 686684 - The origin of human triploids. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Drugs Volume: 32 ISSN: 0012-6667 ISO Abbreviation: Drugs Publication Date: 1986 Aug |
Date Detail:
|
Created Date: 1986-10-22 Completed Date: 1986-10-22 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7600076 Medline TA: Drugs Country: NEW ZEALAND |
Other Details:
|
Languages: eng Pagination: 178-87 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Asthma
/
drug therapy* Bronchodilator Agents / therapeutic use Cromolyn Sodium / therapeutic use Female Fetal Death / etiology Glucocorticoids / therapeutic use Humans Pregnancy Pregnancy Complications / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Bronchodilator Agents; 0/Glucocorticoids; 15826-37-6/Cromolyn Sodium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gamma interferon in psoriatic arthritis
Next Document: Studies of brain stem function in infants with apnea syndrome using acoustically evoked brain stem p...